Peripheral blood stem cell support for multiple cycles of dose intensive induction therapy is feasible with little risk of tumor contamination in advanced stage neuroblastoma: A report from the Childrens Oncology Group-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Peripheral blood stem cell support for multiple cycles of dose intensive induction therapy is feasible with little risk of tumor contamination in advanced stage neuroblastoma: A report from the Childrens Oncology Group

Published:2010-01-04 Issue:4 Volume:54 Page:596-602
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr. Blood Cancer

Author:

Bensimhon Pamela,Villablanca Judith G.,Sender Leonard S.,Matthay Katherine K.,Park Julie R.,Seeger Robert,London Wendy B.,Yap John Stephen F.,Kreissman Susan G.

Funder

Childrens Cancer Group

Childrens Oncology Group

Division of Cancer Treatment, National Cancer Institute, National Institutes of Health, Department of Health and Human Services

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pbc.22344/fullpdf

Reference31 articles.

1. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group;Matthay;N Engl J Med,1999

2. LMCE3 treatment strategy: Results in 99 consecutively diagnosed stage 4 neuroblastomas in children older than 1 year at diagnosis;Frappaz;J Clin Oncol,2000

3. Long-term results for children with high risk neuroblastoma treated on a randomized trial of myeloablative therapy followed by 13-cis-retinoic acid: A Children's Oncology Group Study;Matthay;J Clin Oncol,2009

4. Patterns of relapse after autologous purged bone marrow transplantation for neuroblastoma: A Children's Cancer Group pilot study;Matthay;J Clin Oncol,1993

5. Chemotherapy dose intensity correlates strongly with response, median survival and median progression-free survival in metastatic neuroblastoma;Cheung;J Clin Oncol,1991

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Components of interventions to reduce restrictive practices with children and young people in institutional settings: the Contrast systematic mapping review;Health and Social Care Delivery Research;2022-05

2. High-Risk Neuroblastoma and Current Protocols;Neuroblastoma;2019-08-13

3. Fibrin Gels Entrapment of a Poly-Cyclodextrin Nanocarrier as a Doxorubicin Delivery System in an Orthotopic Model of Neuroblastoma: Evaluation of In Vitro Activity and In Vivo Toxicity;Pharmaceutical Research;2019-06-03

4. Small Split Doses of CD34+Peripheral Blood Stem Cells to Support Repeated Cycles of Nonmyeloablative Chemotherapy;Case Reports in Oncological Medicine;2017

5. The impact of recent vincristine on human hematopoietic progenitor cell collection in pediatric patients with central nervous system tumors;Transfusion;2014-02-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3